| Journal of Translational Medicine | |
| Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation | |
| Research | |
| Ellen Meijer1  Rob Schuurman2  Ronald Jacobi3  Floortje L. Pietersma3  Nening M. Nanlohy3  Esther D. Quakkelaar3  Leonie Ran3  Sanne Spijkers3  Rogier Gaiser3  Henny Otten3  Ingrid M. M. Schellens3  Dan Koning3  Jurgen Kuball4  Suzanne van Dorp4  Debbie van Baarle5  Julia Drylewicz6  | |
| [1] Department of Haematology, VUMC, Amsterdam, The Netherlands;Department of Virology, Utrecht, The Netherlands;Laboratory of Translational Immunology, Department of Immunology, Utrecht, The Netherlands;Laboratory of Translational Immunology, Department of Immunology, Utrecht, The Netherlands;Department of Haematology, Utrecht, The Netherlands;Laboratory of Translational Immunology, Department of Immunology, Utrecht, The Netherlands;Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands;Department of Immune Mechanisms, National Institute for Public Health and the environment (RIVM), Center for Infectious Disease Control, Antonie van leeuwenhoeklaan 9, Bilthoven, The Netherlands;Laboratory of Translational Immunology, Department of Immunology, Utrecht, The Netherlands;Theoretical Biology and Bioinformatics, Department of Biology, Utrecht University, Utrecht, The Netherlands; | |
| 关键词: Stem cell transplantation; CMV; EBV; Immune reconstitution; | |
| DOI : 10.1186/s12967-016-0988-4 | |
| received in 2016-02-04, accepted in 2016-07-26, 发布年份 2016 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundEpstein-Barr virus and Cytomegalovirus reactivations frequently occur after allogeneic stem cell transplantation (SCT).MethodsHere we investigated the role of immune cell reconstitution in the onset and subsequent severity of EBV- and CMV-reactivation. To this end, 116 patients were prospectively sampled for absolute T cell (CD4 and CD8), B-cell (CD19) and NK-cell (CD16 and CD56) numbers weekly post-SCT during the first 3 months and thereafter monthly until 6 months post-SCT. Viral load was monitored in parallel.ResultsIn contrast to the general belief, we found that early T-cell reconstitution does not play a role in the onset of viral reactivation. CMV reactivation in the first 7 weeks after SCT however resulted in higher absolute CD8+ T-cell numbers 6 months post-SCT in patients with high-level reactivation, many of which were CMV-specific. Interestingly, rapid reconstitution of CD4+ T-cells, as well as NK cells and the presence of donor KIR3DL1, are associated with the absence of CMV-reactivation after SCT, suggestive of a protective role of these cells. In contrast, EBV-reactivations were not affected in any way by the level of immune reconstitution after SCT.ConclusionIn conclusion, these data suggest that CD4+ T-cells and NK cells, rather than CD8+ T-cells, are associated with protection against CMV-reactivation.
【 授权许可】
CC BY
© The Author(s) 2016
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311106067871ZK.pdf | 907KB |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
PDF